Zydus Lifesciences completes investment in Torrent Urja 25

Zydus Lifesciences Limited on Wednesday informed exchanges that the company and its subsidiaries have completed the subscription of equity shares in Torrent Urja 25 Private Limited, taking their stake to 22.06% of the company’s paid-up share capital.

According to the exchange filing dated May 20, 2026, Zydus Lifesciences and its subsidiaries had earlier entered into a Share Subscription and Shareholders’ Agreement (SSSAs) to subscribe to equity shares of Torrent Urja 25 in four tranches.

The company said it had earlier invested ₹3.86 crore for subscription of 38,64,792 equity shares under Tranche 1, representing 22.06% of the paid-up share capital of Torrent Urja 25.

Zydus Lifesciences further informed that on May 19, 2026, it invested the remaining ₹9.01 crore for subscription of 90,17,848 equity shares under Tranches 2, 3 and 4.

“With this, the transaction of subscription of shares of Torrent Urja 25 is consummated on May 19, 2026,” the company said in its filing.

Torrent Urja 25 is likely linked to renewable energy and captive power initiatives, aligning with broader industry trends where pharmaceutical companies are increasingly investing in green energy projects to optimise energy costs and support sustainability goals.

The filing was signed by Dhaval Soni, Company Secretary and Compliance Officer of Zydus Lifesciences.

Disclaimer: This article is for informational purposes only and should not be construed as investment advice.